Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs TuHURA Biosciences, Inc. (HURA)

Foghorn Therapeutics Inc. and TuHURA Biosciences, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and TuHURA Biosciences, Inc. are of similar size ($116.6M and $112.2M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −175.8%) and the lower return on invested capital (−74.2% vs 0.00%). Across the 13 metrics below, TuHURA Biosciences, Inc. leads on 7 and Foghorn Therapeutics Inc. on 6.

Valuation

Metric FHTX HURA Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 n/m 9.71
P/B n/m 6.25 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 n/m 0.64
EV/Sales (0.46) n/m 9.21
Earnings yield (52.97%) (30.34%) (33.15%)
Free cash flow yield (64.53%) (26.29%) (25.50%)

Profitability

Metric FHTX HURA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% (163.84%) (56.36%)
Return on assets (30.06%) (92.31%) (48.04%)
Return on invested capital 0.00% (74.20%) 0.00%

Growth

Metric FHTX HURA Biotechnology median
Revenue growth (TTM) 51.98% — 6.02%
EPS growth (last fiscal year) 25.32% 47.93% 30.26%
Revenue growth, 5-year CAGR 135.14% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX HURA Biotechnology median
Debt to equity 0.00 0.47 0.00
Current ratio 3.36 0.18 4.72
Net debt to EBITDA 1.88 0.12 0.96

Dividend

Metric FHTX HURA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FHTX HURA Biotechnology median
Market cap 112.24m 116.62m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack